Skip to main content
Log in

Persistent succinylacetone excretion after liver transplantation in a patient with hereditary tyrosinaemia type I

  • Published:
Journal of Inherited Metabolic Disease

Abstract

A liver transplant was performed on a 4-year-old female in liver failure caused by hereditary tyrosinaemia, with hepatocellular carcinoma following a negative evaluation for metastases. However, serum alpha-fetoprotein levels never returned to normal after the surgery. Urinary succinylacetone (SA) was detected in her urine prior to transplantation despite strict adherence to a low-tyrosine diet. Other patients with severe liver disease awaiting liver transplantation do not excrete SA in the urine. She continued to excrete SA during the postoperative period despite normal liver functions. Oral tyrosine loading resulted in significant elevation of SA excretion. Possible explanations for this observation and clinical and therapeutic relevance are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Berger, R., Smit, G. P. A., Stoker-de-Vries, S. A., Duran, M., Ketting, D. and Wadman, S. K. Deficiency of fumarylacetoacetase in a patient with hereditary tyrosinemia.Clin. Chim. Acta 114 (1981) 37–44

    Article  CAS  Google Scholar 

  • Edwards, S. W. and Knox, W. E. Fumarylacetoacetate hydrolase.Meth. Enzymol. 2 (1955) 298–300

    Google Scholar 

  • Fällstrom, S. P., Lindblad, B., Lindstedt, S. and Steen, G. Hereditary tyrosinemia-fumarylacetoacetase deficiency.Pediatr. Res. 13 (1979) 78

    Article  Google Scholar 

  • Fällstrom, S. P., Lindblad, B. and Steen, G. On the renal tubular damage in hereditary tyrosinemia and on the formation of succinylacetoacetate and succinylacetone.Acta Paediatr. Scand. 70 (1981) 315–320

    Article  Google Scholar 

  • Fisch, R.O., McCabe, E. R. B., Doeden, D., Koep, L. J., Kohlhoff, J. B., Silverman, A. and Starzl, T. E. Homotransplantation of the liver in a patient with hepatoma and hereditary tyrosinemia.J. Pediatr. 93 (1978) 592–596

    Article  CAS  Google Scholar 

  • Furukawa, N., Kinugasa, A., Seo, T., Ishii, T., Ota, T., Machida, Y., Inoue, F., Imashuku, S., Kununoki, T. and Takamatsu, T. Enzyme defect in a case of tyrosinemia type I, acute form.Pediatr. Res. 18 (1984) 463–466

    Article  CAS  Google Scholar 

  • Glaser, J. H. and Sly, W. S. β-Glucuronidase deficiency mucopolysaccharidosis: methods for enzymatic diagnosis.J. Lab. Clin. Med. 82 (1973) 969–977

    CAS  PubMed  Google Scholar 

  • Goldsmith, L. A. Tyrosinemia and related disorders. In Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S., Goldstein, J. L. and Brown, M. S. (eds.)The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, 1983, pp. 287–299

    Google Scholar 

  • Grenier, A., Lescault, A., LaBerge, C., Gagne, R. and Mamer, O. Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia.Clin. Chim. Acta 123 (1979) 93–99

    Article  Google Scholar 

  • Lindblad, B., Lindstedt, S. and Steen, G. On the enzymatic defects in hereditary tyrosinemia.Proc. Natl. Acad. Sci. USA 74 (1977) 4641–4645

    Article  CAS  Google Scholar 

  • Sassa, S. and Kappas, A. Hereditary tyrosinemia and the heme biosynthesis pathway: profound inhibition of δ-aminolevulinic acid dehydratase activity by succinylacetone.J. Clin. Invest. 73 (1983) 625–634

    Article  Google Scholar 

  • Tschudy, D. P., Hess, R. A., Frykholm, B. C. and Blaese, R.M. Immunosuppressive activity of succinylacetone.J. Lab. Clin. Med. 99 (1982) 526–532

    CAS  PubMed  Google Scholar 

  • Tuchman, M., Whitley, C. B., Ramnaraine, M.L., Bowers, L. D., Fregien, K. D. and Krivit, W. Determination of urinary succinylacetone by capillary gas-chromatography.J. Chromatogr. Sci. 22 (1984) 211–215

    Article  CAS  Google Scholar 

  • Wadman, S. K., Duran, M., Ketting, D., Bruinvis, L., Van Sprang, F. J., Berger, R., Smit, G. P. A., Steinmann, B., Leonard, J. V., Divry, P., Farriaux, J. P. and Cartigny, B. Urinary excretion of deuterated metabolites in patients with tyrosinemia type I after oral loading with deuteratedL-tyrosine.Clin. Chim. Acta 130 (1983) 231–238

    Article  CAS  Google Scholar 

  • Weinberg, A. G., Mize, C. E. and Worthen, H. G. The occurrence of hepatoma in the chronic form of hereditary tyrosinemia.J. Pediatr. 88 (1976) 434–438

    Article  CAS  Google Scholar 

  • Weissmann, B. Synthetic substrates for α-L-iduronidase.Meth. Enzymol. 50 (1978) 141–150

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tuchman, M., Freese, D.K., Sharp, H.L. et al. Persistent succinylacetone excretion after liver transplantation in a patient with hereditary tyrosinaemia type I. J Inherit Metab Dis 8, 21–24 (1985). https://doi.org/10.1007/BF01805479

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01805479

Keywords

Navigation